BHC Financials

Income Statement
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025
Revenue
2.9B
+3.1%
2.9B
+13.0%
2.5B
-9.7%
2.8B
+4.3%
2.7B
Cost of Revenue
735.0M
-4.8%
772.0M
+4.6%
738.0M
-7.5%
798.0M
+6.4%
750.0M
Gross Profit
2.2B
+6.1%
2.1B
+16.5%
1.8B
-10.6%
2.0B
+3.5%
1.9B
Operating Expenses
1.2B
-8.7%
1.3B
-51.0%
2.7B
+98.0%
1.4B
+5.3%
1.3B
R&D
141.0M
-18.5%
173.0M
+6.1%
163.0M
+1.2%
161.0M
-3.0%
166.0M
SG&A
834.0M
-8.0%
907.0M
+5.3%
861.0M
-2.4%
882.0M
+10.9%
795.0M
Operating Income
983.0M
+32.8%
740.0M
+177.9%
-950000000
-254.2%
616.0M
-0.5%
619.0M
EBITDA
1.3B
+24.0%
1.0B
+31.4%
784.0M
-31.8%
1.1B
+22.1%
942.0M
Net Income
446.0M
+71.5%
260.0M
+118.2%
-1431000000
-1289.3%
-103000000
-156.9%
181.0M
EPS (Basic)
$1.16
+68.1%
$0.69
+118.1%
$-3.82
-1173.3%
$-0.30
-162.5%
$0.48
EPS (Diluted)
$1.15
+69.1%
$0.68
+117.8%
$-3.82
-1217.2%
$-0.29
-160.4%
$0.48
Shares (Diluted)
380.7M
+0.7%
378.1M
+1.4%
372.8M
-2.4%
381.8M
+1.7%
375.5M
Bausch Health Companies (BHC) — Financials